Literature DB >> 5310207

Poliomyelitis in the world.

W C Cockburn, S G Drozdov.   

Abstract

The incidence of poliomyelitis in different parts of the world is reviewed, mainly from publications of the World Health Organization. In countries of Europe and North America, and in several countries in other regions, the disease has fallen to insignificant proportions. However, in many countries in Africa, Asia, and Central and South America the incidence is rising and large outbreaks are being reported from those areas with increasing frequency. Such outbreaks are not yet as extensive as those previously common in Europe and North America before vaccines came into use but they are growing, and the countries concerned may be faced with widespread epidemics in the future. Where regular programmes of vaccination are not possible (as in many of the countries at risk) plans should be made now to control, by the application of appropriate epidemic control measures, the upsurges of poliomyelitis as soon as they are recognized.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5310207      PMCID: PMC2427528     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  5 in total

1.  THE POLIOMYELITIS IMMUNIZATION PROGRAMME IN SINGAPORE.

Authors:  L H LEE; K A LIM; K KANAGARATNAM
Journal:  Singapore Med J       Date:  1965-06       Impact factor: 1.858

2.  Serological results of oral poliomyelitis vaccine.

Authors:  P A WINTER; L R SAAYMAN; R G SPENCE; E KUHR
Journal:  S Afr Med J       Date:  1963-05-11

3.  Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses.

Authors:  A B SABIN; M RAMOS-ALVAREZ; J ALVAREZ-AMEZQUITA; W PELON; R H MICHAELS; I SPIGLAND; M A KOCH; J M BARNES; J S RHIM
Journal:  JAMA       Date:  1960-08-06       Impact factor: 56.272

4.  Relation of poliomyelitis virus types to clinical disease and geographic distribution: a preliminary report.

Authors:  A SHELOKOV; K HABEL; D W MCKINSTRY
Journal:  Ann N Y Acad Sci       Date:  1955-09-27       Impact factor: 5.691

5.  The immune response to vaccination with inactivated poliovirus vaccine in Sweden.

Authors:  M Böttiger; L Arro; H Lundbeck; C R Salenstedt
Journal:  Acta Pathol Microbiol Scand       Date:  1966
  5 in total
  14 in total

1.  Depression of humoral and cell-mediated immune responses by coxsackieviruses in mice.

Authors:  M Bendinelli; A Ruschi; M Campa; A Toniolo
Journal:  Experientia       Date:  1975-10-15

2.  Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia.

Authors:  Haider Al-Hello; Jaume Jorba; Soile Blomqvist; Riina Raud; Olen Kew; Merja Roivainen
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

3.  Potency of field samples of oral poliovirus vaccine.

Authors:  S C Arya; M I Sharma; J B Shrivastav; P S Ramachandran
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

4.  Potency Titration of Oral Polio Vaccine by Estimation of Live Virus Content Using Tissue Culture Technique.

Authors:  Shiva Priya Eswaran; A K Praharaj; Y Chander; A Nagendra
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 5.  Success and failure in human virus disease. IV. Immunization.

Authors:  C Stuart-Harris
Journal:  Br Med J       Date:  1971-02-20

6.  Advantages and disadvantages of killed and live poliomyelitis vaccines.

Authors:  J L Melnick
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

7.  [Advantages and inconveniences of inactive and live antipoliomyelitis vaccines].

Authors:  J L Melnick
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

8.  Epidemiological models of poliomyelitis and measles and their application in the planning of immunization programmes.

Authors:  B Cvjetanović; B Grab; H Dixon
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

9.  Routine administration of oral polio vaccine in a subtropical area. Factors possibly influencing sero-conversion rates.

Authors:  T A Swartz; P Skalska; C G Gerichter; W C Cockburn
Journal:  J Hyg (Lond)       Date:  1972-12

10.  Neurological diseases associated with viral and Mycoplasma pneumoniae infections.

Authors:  F Assaad; R Gispen; M Kleemola; L Syrůcek; K Esteves
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.